Log in to search using one of your social media accounts:

 

FDA panel unanimously votes to approve gene therapy for blindness

A US Food and Drug Administration advisory committee unanimously voted Thursday to approve an experimental genetic therapy for patients with a rare inherited eye disease.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

TRENTON, N.J. (CBS/AP) — U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults. The Food and Drug Administration allowed sales of the treatment from Kite Pharma. It uses the same technology, called CAR-T, as the first gene therapy approved in the U.S. in August, a treatment for childhood leukemia from Novartis Pharmaceuticals. That Novartis treatment was tested in Boston. In those tests, Dana Farber and Brigham and Women’s Hospital cancer researchers found that 80 percent of lymphoma patients who underwent the treatmen...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Healthwatch Local News blood cancer Brigham and Women's Hospital Dana Farber FDA Gene Therapy Novartis Pharmaceuticals Source Type: news
Publication date: Available online 16 October 2017 Source:Progress in Retinal and Eye Research Author(s): Dimitra Athanasiou, Monica Aguila, James Bellingham, Wenwen Li, Caroline McCulley, Philip J. Reeves, Michael E. Cheetham Inherited mutations in the rod visual pigment, rhodopsin, cause the degenerative blinding condition, retinitis pigmentosa (RP). Over 150 different mutations in rhodopsin have been identified and, collectively, they are the most common cause of autosomal dominant RP (adRP). Mutations in rhodopsin are also associated with dominant congenital stationary night blindness (adCSNB) and, less frequently, re...
Source: Progress in Retinal and Eye Research - Category: Opthalmology Source Type: research
An experimental gene therapy for a rare hereditary form of blindness is a step closer to reality. An FDA advisory panel voted unanimously Thursday to recommend approval of a groundbreaking treatment for people with a faulty gene that impairs vision. It would be the first gene therapy in the U.S. for an inherited disease. Dr. David Agus joins "CBS This Morning" to discuss how the treatment works and why it could be a new frontier in treating genetic disorders.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
The FDA advisory committee gave a unanimous thumbs-up to gene therapy for one form of inherited blindness, paving the way for others.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news
If approved, it would be the first gene therapy in the U.S. for an inherited disease
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
An FDA advisory panel weighed in on a therapy that can improve the vision of people with a rare genetic disorder called Leber's congenital amaurosis (LCA)
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
An experimental gene therapy for a rare hereditary form of blindness is a step closer to reality. An FDA advisory panel voted unanimously Thursday to recommend approval of a groundbreaking treatment for people with a faulty gene that impairs vision. It would be the first gene therapy in the U.S. for an inherited disease. Dr. David Agus joins "CBS This Morning" to discuss how the treatment works and why it could be a new frontier in treating genetic disorders.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
An FDA advisory panel gave the green light for a therapy that can improve the vision of people with a rare genetic disorder called Leber's congenital amaurosis (LCA)
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
An experimental treatment for a certain cause of blindness is a step closer to approval. An FDA advisory panel approved the therapy, which can improve the vision of people with a rare genetic disorder. Errol Barnett has more.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
If approved, it would be the first gene therapy in the U.S. for an inherited disease
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
More News: Blindness | Food and Drug Administration (FDA) | Gene Therapy | Genetics | Health | Opthalmology